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While the US administration has
ongoing concern about the use of
human embryo-derived stem cells in
research, three scientists who played a
key part in opening up this field share
this year’s Lasker Award for basic
medical research. Martin Evans of the
University of Wales, Cardiff, first
purified stem cells from mouse
embryos. Mario Capecchi of the
University of Utah, Salt Lake City
and Oliver Smithies of the University
of North Carolina, Chapel Hill used
homologous recombination to target
specific genes in cells. The scientists’
work converged to produce the first
knockout mice in 1989.
Robert Edwards of the University
of Cambridge (UK) received the
award for clinical medical research.
Working with colleague Patrick
Steptoe of Oldham and District
General Hospital, Edwards developed
the in vitro fertilization (IVF)
technology that culminated in the
birth of the first test tube baby in
1978. Steptoe died in 1988. In
addition, William Foege of Emory
University received the public service
award for his work in public health; in
particular, his pivotal role in
eradicating smallpox. Foege was
director of the Centers for Disease
Control from 1977 to 1983.
Gene targeting technology started
when Martin Evans, a graduate
student at University College London,
began to work with embryonic
carcinoma (EC) cells — cells that give
rise to a tumor called teratocarcinoma,
which is composed on many different
tissue types. According to Evans, he
was the first to be able to maintain EC
cells in culture under conditions where
their ability to differentiate was
retained indefinitely. 
After Evans started research in his
own lab in Cambridge, he was able,
together with colleague Matt
Kaufman, to isolate cells with
properties similar to EC cells from
normal mouse embryos. The first
description of the so-called mouse
embryonic stem (ES) cells was
published in 1981. Subsequently,
Evans’ group, which included
postdoctoral fellow Liz Robertson and
student Allan Bradley, showed that
ES cells in culture could be used to
fully regenerate fertile breeding mice.
Evans and others also showed that
genetic alterations could be
introduced in ES cells, albeit in a
somewhat random fashion, to
generate mutant mice.
It was not until Capecchi and
Smithies developed a technique to
target a specific gene in ES cells and
replace it with a defective mutant
copy that ES cell technology could be
used for its now most common
application: the generation of
knockout mice. In 1982, Capecchi
showed that mammalian cells contain
an efficient enzymatic machinery for
mediating homologous recombination.
The next step, pursued by both
Capecchi and Smithies, was to show
that a cell could be ‘tricked’ to carry
out homologous recombination at a
chosen location. Because the
efficiency of gene targeting was low,
Capecchi subsequently developed a
general strategy for enriching cells
that have taken up foreign DNA and
eliminating those cells that have
allowed integration at random sites
(positive-negative selection). As a
result, any gene could now be
targeted in any cell, including the
recently isolated ES cells. In 1989,
several groups — which also included
those of Rudolph Jaenish at the
Whitehead Institute and Nick Maeda
at the University of Chapel
Hill — reported the creation of mice
deficient in a specific gene.
“Since the beginning we were
aware that we had to make a
technique that was friendly to the
operator,” says Capecchi. “We were
really pleased at how widely used
[gene targeting] became.” Another
accomplishment, according to
Capecchi, is that any lab, regardless of
size, can carry out the procedure. 
Robert Edwards first achieved
fertilization completely outside a
woman’s body in 1969, and only three
years later began transferring embryos
grown in the lab into infertile
mothers. Edwards worked with
Steptoe, who was responsible for
retrieving the egg by laparoscopy.
Together they succeeded, in 1978, in
creating the first IVF baby. In 1980,
they founded one of the first IVF
clinics in the world at Bourn Hall in
Cambridge. Since then, almost one
million babies worldwide have been
born by assisted reproductive
technology.
ES stem cell research and
reproductive technology are currently
at the center of intense public debate
in the US. On August 9, President
Bush announced that for the first time
federal funds could be used for
human ES cell research, although on a
limited number of cell lines.
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This year’s Lasker Awards for basic medical research were presented
to scientists credited with establishing gene knockout technology
which paved the way to current interest in the research potential
of stem cells. Laura Bonetta reports.
